réalisée sur le porc, a montré les mêmes résultats. La cicatrisation muqueuse ayant été observée après 12 semaines et la reformation osseuse entre 12 semaines et 12 mois Ces deux études montrent que l'injection systémique de CSM permet la cicatrisation des sites d'ONM chez l'animal. Des études cliniques sur l'homme n ,
implants n'est pas contre-indiquée chez les patients traités par biphosphonates oraux pour une ostéoporose. Une évaluation rigoureuse pré chirurgicale de l'ensemble des facteurs de risque est nécessaire, p.97 ,
implants est également possible chez les patients ayant une ostéoporose traitée par biphosphonates intra-veineux après la même évaluation des facteurs de risque. Cependant le patient devra être informé de l'absence de données concernant le risque associé à la pose d'implant chez ce type de patient, p.97 ,
Manuel d'histologie et de biologie buccale, 1989. ,
Oral anatomy, histology and embryology. 3 e éd. Londres: Mosby, 2002. ,
Histologie de l'os normal. EMC Appareil locomoteur, pp.1-1, 1995. ,
Bone loss. Factors that regulate osteoclast differentiation: an update, Arthritis Research, vol.2, issue.6, pp.451-457, 2000. ,
DOI : 10.1186/ar127
URL : https://hal.archives-ouvertes.fr/hal-00966726
Histophysiologie du parodonte. EMC Médecine buccale, pp.1-23, 2012. ,
Anatomie tête et cou en odontostomatologie ,
Bisphosphonates: how do they work?, Best Practice & Research Clinical Endocrinology & Metabolism, vol.22, issue.5, pp.831-878, 2008. ,
DOI : 10.1016/j.beem.2008.07.001
M??dicaments de l???ost??oporose, Actualit??s Pharmaceutiques, vol.53, issue.533, pp.53-59, 2014. ,
DOI : 10.1016/j.actpha.2013.12.014
Novel applications related to bisphosphorus compounds Kuopio: University of Eastern Finland; 2014. [consulté le 19, Disponible sur, 2014. ,
Denosumab and bisphosphonates: Different mechanisms of action and effects, Bone, vol.48, issue.4, pp.677-92, 2011. ,
DOI : 10.1016/j.bone.2010.11.020
Pharmacology of bisphosphonates, Bone, vol.49, issue.1, pp.42-51, 2011. ,
DOI : 10.1016/j.bone.2011.01.014
Actualisation 2012??des recommandations fran??aises du traitement m??dicamenteux de l???ost??oporose post-m??nopausique, Revue du Rhumatisme, vol.79, issue.3, pp.264-74, 2012. ,
DOI : 10.1016/j.rhum.2012.02.006
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw?2014 Update, J Oral Maxillofac Surg, vol.72, issue.10, pp.20141938-56 ,
Les SERM(s), Revue du Rhumatisme, vol.73, issue.8, pp.828-861, 2006. ,
DOI : 10.1016/j.rhum.2006.05.007
Les SERMs dans le traitement de l'ost??oporose??: ??tat des lieux et perspectives, Gyn??cologie Obst??trique & Fertilit??, vol.34, issue.5, pp.423-431, 2006. ,
DOI : 10.1016/j.gyobfe.2006.03.004
Selective Estrogen-Receptor Modulators ??? Mechanisms of Action and Application to Clinical Practice, New England Journal of Medicine, vol.348, issue.7, pp.618-647, 2003. ,
DOI : 10.1056/NEJMra022219
EVISTA 60mg cp pellic [en ligne, Disponible sur, 2014. ,
Osteonecrosis of the jaw in a patient on raloxifene: a case report, Quintessence Int, vol.46, issue.5, pp.423-431, 2015. ,
Le t??riparatide, Revue du Rhumatisme, vol.73, issue.8, pp.838-883, 2006. ,
DOI : 10.1016/j.rhum.2006.06.003
Teriparatide: A review, Clinical Therapeutics, vol.26, issue.6, pp.841-54, 2004. ,
DOI : 10.1016/S0149-2918(04)90128-2
Parathyroid hormone for osteoporosis treatment, Formosan Journal of Musculoskeletal Disorders, vol.2, issue.4, pp.113-120, 2011. ,
DOI : 10.1016/j.fjmd.2011.09.001
Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis, Joint Bone Spine, vol.70, issue.6, pp.465-70, 2003. ,
DOI : 10.1016/j.jbspin.2003.08.002
Le ran??late de??strontium, Revue du Rhumatisme, vol.73, issue.8, pp.834-841, 2006. ,
DOI : 10.1016/j.rhum.2006.05.008
Ran??late de strontium : une nouvelle approche de l'ost??oporose post-m??nopausique, Revue du Rhumatisme, vol.72, pp.16-22, 2005. ,
DOI : 10.1016/S1169-8330(05)80004-3
Ran??late de strontium (Protelos??)??: effets ind??sirables rapport??s en France, La Presse M??dicale, vol.40, issue.10, pp.453-62, 2011. ,
DOI : 10.1016/j.lpm.2011.07.010
Nouvelles cibles th??rapeutiques dans l???ost??oporose, Revue du Rhumatisme, vol.77, issue.3, pp.257-63, 2010. ,
DOI : 10.1016/j.rhum.2009.10.032
Innovations th??rapeutiques dans l???ost??oporose (anticorps antiscl??rostine et denosumab), Annales d'Endocrinologie, vol.72, pp.15-22, 2011. ,
DOI : 10.1016/S0003-4266(11)70005-1
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis, Disponible sur, pp.2011-2035, 2014. ,
DOI : 10.14219/jada.archive.2011.0108
Lettre aux professionnels de santé : Denosumab 60mg (PROLIA) : mise à jour des informations de sécurité d'emploi afin de minimiser les risques d'ostéonécrose de la mâchoire et d'hypocalcémie [en ligne]. 2014 [consulté le 13, Disponible sur, 2014. ,
Lettre aux professionnels d santé : Denosumab 120mg (XGEVA) : mise à hour des informations de sécurité d'emploi pour minimiser les risques d'ostéonécrose de la mâchoire et d'hypocalcémie [en ligne]. 2014 [consulté le 13, Disponible sur, 2014. ,
Prévention, diagnostic et traitement de l'ostéoporose : note de synthèse [en ligne], Disponible sur, 2006. ,
Oral implications of osteoporosis, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.100, issue.3, pp.349-56, 2005. ,
DOI : 10.1016/j.tripleo.2005.04.010
Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis, Maturitas, vol.59, issue.3, pp.226-259, 2008. ,
DOI : 10.1016/j.maturitas.2008.01.006
A novel method of dental panoramic tomogram analysis: A perspective tool for a screening test for osteoporosis, Journal of Cranio-Maxillofacial Surgery, vol.41, issue.8, pp.808-823, 2013. ,
DOI : 10.1016/j.jcms.2013.01.033
Osteoporosis: diagnosis, prevention, therapy, 2009. ,
Relationship Between Osteoporosis and Periodontal Disease: Review of the Literature, J Dent Tehran Univ Med Sci, vol.9, issue.4, pp.256-64, 2012. ,
3 e éd. Issy-les-Moulineaux: Masson, 2005. ,
exploration biochimique du remodelage osseux dans l'ostéoporose : quels marqueurs utiliser ? Rev Francoph Lab, pp.43-51, 2012. ,
DOI : 10.1016/s1773-035x(12)71734-3
Nouveaux marqueurs biologiques du remodelage osseux dans l???ost??oporose, M??decine Nucl??aire, vol.33, issue.1, pp.17-27, 2009. ,
DOI : 10.1016/j.mednuc.2008.09.008
Recommandations pour le suivi des traitements antir??sorptifs au cours de l???ost??oporose postm??nopausique, Revue du Rhumatisme, vol.72, issue.1, pp.27-33, 2005. ,
DOI : 10.1016/j.rhum.2004.07.006
Correlations between seven panoramic radiomorphometric indices and bone mineral density in postmenopausal women, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.109, issue.3, pp.449-56, 2010. ,
DOI : 10.1016/j.tripleo.2009.02.028
Accuracy in osteoporosis diagnosis of a combination of mandibular cortical width measurement on dental panoramic radiographs and a clinical risk index (OSIRIS): The OSTEODENT project, Bone, vol.40, issue.1, pp.223-232, 2007. ,
DOI : 10.1016/j.bone.2006.07.025
Diagnosing osteoporosis by using dental panoramic radiographs: The OSTEODENT project, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.104, issue.6, pp.821-829, 2007. ,
DOI : 10.1016/j.tripleo.2006.12.027
The use of visual assessment of dental radiographs for identifying women at risk of having osteoporosis: the OSTEODENT project, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.106, issue.2, pp.285-93, 2008. ,
DOI : 10.1016/j.tripleo.2007.09.008
The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.110, issue.2, pp.243-252, 2010. ,
DOI : 10.1016/j.tripleo.2010.03.035
Periodontal Diseases and Osteoporosis: Association and Mechanisms, Annals of Periodontology, vol.127, issue.1, pp.197-208, 2001. ,
DOI : 10.1177/00220345970760100601
Evaluation of the Association Between Periodontal Parameters, Osteoporosis and Osteopenia in Post Menopausal Women, J Dent Tehran Univ Med Sci, vol.10, issue.5, pp.443-451, 2013. ,
Comparison of mandibular bone in normal and osteoporotic women, The Journal of Prosthetic Dentistry, vol.63, issue.2, pp.218-240, 1990. ,
DOI : 10.1016/0022-3913(90)90108-O
Oral Bone Loss May Be Influenced by Infection and Osteoporosis, Journal of Evidence Based Dental Practice, vol.9, issue.2, pp.99-100, 2009. ,
DOI : 10.1016/j.jebdp.2009.03.009
The effect of osteoporosis on residual ridge resorption and masticatory performance in denture wearers, Gerodontology, vol.27, issue.2, pp.1059-66, 2012. ,
DOI : 10.1111/j.1741-2358.2009.00324.x
Paget???s disease of the mandible, Journal of Oral and Maxillofacial Pathology, vol.16, issue.1, pp.107-116, 2012. ,
DOI : 10.4103/0973-029X.92984
Paget's disease of bone with particular reference to dentistry, Journal of Oral Pathology and Medicine, vol.30, issue.7, pp.233-280, 1981. ,
DOI : 10.1016/0030-4220(54)90291-1
Paget's Disease of Maxilla, World Journal of Dentistry, vol.2, issue.1, pp.49-51, 2011. ,
DOI : 10.5005/jp-journals-10015-1053
Maladie de Paget : aspects radiologiques, Feuill Radiol, vol.38, issue.4, p.297, 1998. ,
Paget's Disease of the Bone: a Clinical Report, Acta Stomatol Croat, vol.45, issue.2, pp.125-155, 2011. ,
Paget's disease of bone: current concepts in pathogenesis and treatment, Journal of Oral Pathology and Medicine, vol.98, issue.1, pp.12-18, 1994. ,
DOI : 10.1016/S0901-5027(05)80242-5
Multiple root resorption as a presenting sign of Paget's disease of bone, Oral Surgery, vol.25, issue.1, pp.53-58, 2008. ,
DOI : 10.1111/j.1600-0714.1981.tb01270.x
Use of zoledronic acid in the treatment of Paget's disease, Ther Clin Risk Manag, vol.3, issue.5, pp.913-921, 2007. ,
Place des bisphosphonates dans le traitement de la maladie osseuse de Paget, Revue du Rhumatisme, vol.70, issue.8, pp.658-61, 2003. ,
DOI : 10.1016/S1169-8330(03)00295-3
Maladie osseuse de Paget, EMC - Trait?? de m??decine AKOS, vol.2, issue.2, pp.1-7, 2007. ,
DOI : 10.1016/S1634-6939(07)39649-X
Bisphosphonates for cancer patients: why, how, and when? Support Care Cancer, pp.399-407, 2002. ,
Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease, European Journal of Cancer, vol.46, issue.7, pp.1211-1233, 2010. ,
DOI : 10.1016/j.ejca.2010.02.041
Pr??vention osseuse dans le traitement du cancer de la prostate, Progr??s en Urologie, vol.21, issue.2, pp.58-62, 2011. ,
DOI : 10.1016/S1166-7087(11)70013-6
Denosumab for treatment of bone metastases secondary to solid tumours: Systematic review and network meta-analysis, European Journal of Cancer, vol.49, issue.2, pp.416-446, 2013. ,
DOI : 10.1016/j.ejca.2012.07.016
??valuation du risque d???ost??on??crose des maxillaires sous d??nosumab, Revue du Rhumatisme, vol.81, issue.2, pp.191-193, 2014. ,
DOI : 10.1016/j.rhum.2013.05.012
Implantologie et Biphosphonates : recommandations de bonne pratique [en ligne]. 2012 [consulté le 09 Disponible sur: http://www.sfscmfco.fr/wp- content/uploads, 2012. ,
Ostéonécrose des mâchoires en chirurgie oromaxillofaciale et traitements médicamenteux à risque (antirésorbeurs osseux, antiangiogéniques) : recommandations de bonne pratique [en ligne]. 2012 [consulté le 09, Disponible sur, 2012. ,
Ost??on??crose de la machoire sous biphosphonates??: aspects radiologiques, Journal de Radiologie, vol.90, issue.2, pp.199-205, 2009. ,
DOI : 10.1016/S0221-0363(09)72470-9
Imaging Findings in Bisphosphonate-Related Osteonecrosis of Jaws, Journal of Oral and Maxillofacial Surgery, vol.67, issue.5, pp.75-84, 2009. ,
DOI : 10.1016/j.joms.2008.12.002
Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ), Oral Diseases, vol.82, issue.5 Suppl, pp.621-624, 2012. ,
DOI : 10.1177/154405910308200806
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients, Clinical Radiology, vol.63, issue.1, pp.71-78, 2008. ,
DOI : 10.1016/j.crad.2007.04.023
Emerging Concepts in the Management and Treatment of Osteonecrosis of the Jaw, Oral and Maxillofacial Surgery Clinics of North America, vol.25, issue.1, pp.11-20, 2013. ,
DOI : 10.1016/j.coms.2012.10.002
Diabetes Microvascular Disease and the Risk for bisphosphonate-related Osteonecrosis of the Jaw: A Single Center Study, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.11, pp.1807-1819, 2013. ,
DOI : 10.1210/jc.2013-2434
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases, Annals of Oncology, vol.49, issue.18s, pp.1341-1348, 2012. ,
DOI : 10.1016/j.bjoms.2010.05.007
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw, Journal of Clinical Oncology, vol.27, issue.32, pp.5356-62, 2009. ,
DOI : 10.1200/JCO.2009.21.9584
Informations-de-securite-Lettres-aux- professionnels-de-sante/Traitement-par-sunitinib-Sutent-R-Osteonecrose-de-la- machoire-chez-les-patients-ayant-recu-precedemment ,
Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone, Oncology, vol.76, issue.3, pp.209-220, 2009. ,
DOI : 10.1159/000201931
Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients, Bone, vol.58, pp.103-110, 2014. ,
DOI : 10.1016/j.bone.2013.10.002
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer, Breast Cancer Research and Treatment, vol.25, issue.18S, pp.181-189, 2010. ,
DOI : 10.7326/0003-4819-144-10-200605160-00009
URL : https://hal.archives-ouvertes.fr/hal-00535451
Osteonecrosis of the mandible associated with bevacizumab therapy, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol.115, issue.6, pp.32-38, 2013. ,
DOI : 10.1016/j.oooo.2013.02.001
Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?, Annals of Oncology, vol.79, issue.1, pp.600-601, 2009. ,
DOI : 10.1111/j.1600-0609.2007.00872.x
Osteonecrosis of The Jaw: Dental Outcomes in Metastatic Breast Cancer Patients Treated With Bisphosphonates With/Without Bevacizumab, Clinical Breast Cancer, vol.11, issue.4, pp.252-259, 2011. ,
DOI : 10.1016/j.clbc.2011.02.001
Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma, Bone, vol.44, issue.1, pp.173-178, 2009. ,
DOI : 10.1016/j.bone.2008.08.132
Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implications, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol.113, issue.2, pp.234-242, 2012. ,
DOI : 10.1016/j.tripleo.2011.08.024
Osteonecrosis of the jaw related to sunitinib, Oral and Maxillofacial Surgery, vol.28, issue.1, pp.63-69, 2011. ,
DOI : 10.1007/BF00314866
Sunitinib related osteonecrosis of jaw: a case report, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol.113, issue.3, pp.1-3, 2012. ,
DOI : 10.1016/j.tripleo.2011.06.023
Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.110, issue.4, pp.463-472, 2010. ,
DOI : 10.1016/j.tripleo.2010.04.049
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases, British Journal of Cancer, vol.19, issue.10, pp.1665-71, 2012. ,
DOI : 10.1002/ijc.24470
Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents, Future Oncology, vol.16, issue.2, pp.257-75, 2014. ,
DOI : 10.1016/j.bjoms.2011.08.004
Lettre aux professionnels de santé pharmacovigilance : recommandations sur la prise en charge bucco-dentaire des patients traités par bisphosphonates [en ligne] Disponible sur: http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels- de-sante/Recommandations-sur-la-prise-en-charge-bucco-dentaire-des-patients- traites-par-bisphosphonates, 2007. ,
Ostéonécrose des mâchoires en chirurgie oromaxillofaciale et traitements médicamenteux à risque (antirésorbeurs osseux, antiangiogéniques) : recommandations de bonne pratique [en ligne]. 2013 [consulté le 06, Disponible sur, 2012. ,
Osteonecrosis of the jaw ??? Prevention and treatment strategies for oral health professionals, Oral Oncology, vol.49, issue.9, pp.878-86, 2013. ,
DOI : 10.1016/j.oraloncology.2013.06.008
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience, Annals of Oncology, vol.26, issue.24, pp.193-200, 2012. ,
DOI : 10.1200/JCO.2007.15.5424
Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients, J Can Dent Assoc, vol.77, p.147, 2011. ,
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid, Annals of Oncology, vol.110, issue.11, pp.117-137, 2009. ,
DOI : 10.1038/sj.leu.2404682
Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays, Gen Dent, vol.61, issue.5, pp.33-41, 2013. ,
Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases, Oral Oncology, vol.48, issue.5, pp.469-74, 2012. ,
DOI : 10.1016/j.oraloncology.2011.12.004
Bisphosphonate-Related Osteonecrosis of the Jaws???An Initial Case Series Report of Treatment Combining Partial Bone Resection and Autologous Platelet-Rich Plasma, Journal of Oral and Maxillofacial Surgery, vol.69, issue.9, pp.2465-72, 2011. ,
DOI : 10.1016/j.joms.2011.02.078
Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw, International Journal of Oral and Maxillofacial Surgery, vol.41, issue.11, pp.1410-1415, 2012. ,
DOI : 10.1016/j.ijom.2012.04.020
Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: A pilot study comparing fibrin rich in growth factors and teriparatide, Medicina Oral Patolog??a Oral y Cirugia Bucal, vol.19, issue.4, pp.320-326, 2014. ,
DOI : 10.4317/medoral.19458
Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy, Medicina Oral Patolog??a Oral y Cirugia Bucal, vol.18, issue.4, pp.680-685, 2013. ,
DOI : 10.4317/medoral.18812
Doxycycline fluorescence-guided Er:YAG laser ablation combined with Nd:YAG/diode laser biostimulation for treating bisphosphonate-related osteonecrosis of the jaw, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol.119, issue.1, pp.6-12, 2015. ,
DOI : 10.1016/j.oooo.2014.04.014
Effects of low-level laser therapy on the proliferation and apoptosis of gingival fibroblasts treated with zoledronic acid, International Journal of Oral and Maxillofacial Surgery, vol.43, issue.8, pp.1030-1034, 2014. ,
DOI : 10.1016/j.ijom.2014.02.011
Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid, Supportive Care in Cancer, vol.42, issue.10, pp.2741-2749, 2014. ,
DOI : 10.1016/j.ijom.2012.03.026
Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.110, issue.6, pp.1-6, 2010. ,
DOI : 10.1016/j.tripleo.2010.08.013
Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients, Journal of Osteoporosis, vol.77, issue.2, p.585434, 2012. ,
DOI : 10.1089/pho.2007.2181
Utility of Hyperbaric Oxygen in Treatment of Bisphosphonate-Related Osteonecrosis of the Jaws, Journal of Oral and Maxillofacial Surgery, vol.67, issue.5, pp.96-106, 2009. ,
DOI : 10.1016/j.joms.2008.12.003
Hyperbaric Oxygen Treatment and Bisphosphonate-Induced Osteonecrosis of the Jaw: A Case Series, Journal of Oral and Maxillofacial Surgery, vol.65, issue.7, pp.1321-1328, 2007. ,
DOI : 10.1016/j.joms.2007.03.019
What Is the Role of Hyperbaric Oxygen in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw: A Randomized Controlled Trial of Hyperbaric Oxygen as an Adjunct to Surgery and Antibiotics, Journal of Oral and Maxillofacial Surgery, vol.70, issue.7, pp.1573-83, 2012. ,
DOI : 10.1016/j.joms.2012.04.001
Efficacy and safety of medical ozone (O3) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I???II study, Oral Oncology, vol.47, issue.3, pp.185-90, 2011. ,
DOI : 10.1016/j.oraloncology.2011.01.002
Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients, Haematologica, vol.92, issue.9, pp.1289-90, 2007. ,
DOI : 10.3324/haematol.11096
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study, Blood Cancer Journal, vol.294, issue.3, p.62, 2012. ,
DOI : 10.1001/jama.294.16.2035
Bisphosphonaterelated osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy, Eur Rev Med Pharmacol Sci, vol.16, issue.12, pp.1741-1748, 2012. ,
Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates???Preliminary data, Journal of Bone Oncology, vol.1, issue.3, pp.81-88, 2012. ,
DOI : 10.1016/j.jbo.2012.08.001
Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)], Journal of Oral and Maxillofacial Surgery, vol.65, issue.3, pp.573-80, 2007. ,
DOI : 10.1016/j.joms.2006.10.076
Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws, Osteoporosis International, vol.11, issue.Suppl 1, pp.2721-2726, 2012. ,
DOI : 10.1007/PL00004183
Teriparatide Therapy for Denosumab-Induced Osteonecrosis of the Jaw in a Male Osteoporotic Patient, Calcified Tissue International, vol.26, issue.1, pp.94-100, 2014. ,
DOI : 10.1002/jbmr.335
Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy, The Journal of Rheumatology, vol.36, issue.8, pp.1835-1842, 2009. ,
DOI : 10.3899/jrheum.081176
Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws, Osteoporosis International, vol.18, issue.9, pp.2365-2374, 2013. ,
DOI : 10.1359/jbmr.2003.18.11.1932
Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up, The Open Dentistry Journal, vol.7, issue.1, pp.94-101, 2013. ,
DOI : 10.2174/1874210601307010094
Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.110, issue.5, pp.593-599, 2010. ,
DOI : 10.1016/j.tripleo.2010.05.067
Pentoxifylline and Tocopherol in the Treatment of Yearly Zoledronic Acid???Related Osteonecrosis of the Jaw in a Corticosteroid-Induced Osteoporosis, Journal of Oral and Maxillofacial Surgery, vol.72, issue.2, pp.334-341, 2014. ,
DOI : 10.1016/j.joms.2013.06.188
Geranylgeraniol ??? A new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw, Oral Oncology, vol.47, issue.3, pp.195-201, 2011. ,
DOI : 10.1016/j.oraloncology.2010.12.003
Novel Therapy to Reverse the Cellular Effects of Bisphosphonates on Primary Human Oral Fibroblasts, Journal of Oral and Maxillofacial Surgery, vol.69, issue.10, pp.2564-78, 2011. ,
DOI : 10.1016/j.joms.2011.03.005
Infection, vascularization, remodelling -are stem cells the answers for bone diseases of the jaws? Head Face Med, p.5, 2011. ,
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw, Head & Face Medicine, vol.7, issue.7, p.16, 2011. ,
DOI : 10.1186/1746-160X-7-5
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice, Journal of Bone and Mineral Research, vol.37, issue.7, pp.1668-79, 2010. ,
DOI : 10.7326/0003-4819-144-10-200605160-00009
Allogeneic Mesenchymal Stem Cell Therapy for Bisphosphonate-Related Jaw Osteonecrosis in Swine, Stem Cells and Development, vol.22, issue.14, pp.2047-56, 2013. ,
DOI : 10.1089/scd.2012.0615